Hillsdale Investment Management Inc. Emergent Bio Solutions Inc. Transaction History

Hillsdale Investment Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$50.07 - $66.05 $1.81 Million - $2.39 Million	-36,200 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$86.23 - $125.19 $758,824 - $1.1 Million	-8,800 Reduced 19.56%	36,200 $3.36 Million
Q4 2020 Feb 09, 2021	SELL	$79.17 - $111.47 $23,751 - $33,441	-300 Reduced 0.66%	45,000 $4.03 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $1.05 Million - $1.73 Million	-12,800 Reduced 22.03%	45,300 $4.68 Million
Q2 2020 Aug 11, 2020	SELL	$54.33 - $89.52 $146,691 - $241,704	-2,700 Reduced 4.44%	58,100 $4.59 Million
Q1 2020 May 12, 2020	BUY	$49.34 - $68.76 $3 Million - $4.18 Million	60,800 New	60,800 $3.52 Million
Q2 2018 Aug 13, 2018	SELL	$48.33 - $55.64 $1.45 Million - $1.66 Million	-29,900 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $1.13 Million - $1.43 Million	29,900	29,900 $1.39 Million

158

32.6M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $385M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.